Zobrazeno 1 - 10
of 62
pro vyhledávání: '"MELEK KARAKURT ERYILMAZ"'
Publikováno v:
Ahi Evran Medical Journal, Vol 6, Iss 1, Pp 26-31 (2022)
Purpose: Lymph node ratio (LNR) represents the ratio of positive lymph nodes to total excised lymph nodes. We analyzed the correlation between LNR and outcomes in patients who have undergone surgery for SCC of the head and neck. Materials and Method
Externí odkaz:
https://doaj.org/article/d8566abe586c47ccbe0c55fd8dd662a5
Autor:
Mustafa Karaagac, Mehmet Artac, Caglayan Geredeli, Melek Karakurt Eryilmaz, Mahmut Selman Yildirim, Tuba Akkuloglu, Ali Inal, Abdurrahman Isikdogan, Hakan Bozcuk, Ahmet Demirkazik
Publikováno v:
Medicine Science, Vol 9, Iss 1, Pp 255-60 (2020)
Results from studies in several cancers on single nucleotide polymorphisms (SNPs) suggest that DNA repair capacity may have prognostic implication for disease recurrence, survival, and responses to treatment. This study aimed to evaluate the potentia
Externí odkaz:
https://doaj.org/article/4f9cba6494ec43678eddb650bbf753de
Autor:
Mehmet Zahid Kocak, Murat Cakir, Ulku Kerimoglu, Murat Araz, Melek Karakurt Eryilmaz, Perran Fulden Yumuk, Mehmet Artac
Publikováno v:
Oncology in Clinical Practice. 19:114-117
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6a37cf9932d0a3091c386bc128ef9ee
https://doi.org/10.5603/ocp.2023.0004
https://doi.org/10.5603/ocp.2023.0004
Publikováno v:
Akdeniz Medical Journal. 9:30-36
Aim: The aim of this study was to evaluate clinicopathological characteristics and prognostic factors of patients with breast cancer (BC) aged 30 and under. Materials and methods: We retrospectively analyzed BC patients aged 30 and under who were tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f37f0489a69c447b00f4446c29db5d85
https://doi.org/10.53394/akd.979443
https://doi.org/10.53394/akd.979443
Publikováno v:
Brazilian Journal of Otorhinolaryngology. 88:S188-S191
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cee69400b452d5c1bdc56ff5127dbaa0
https://doi.org/10.1016/j.bjorl.2021.03.007
https://doi.org/10.1016/j.bjorl.2021.03.007
Autor:
Neslihan Özyurt, Ali Alkan, Burcu Gülbağcı, Mustafa Seyyar, Esra Aydın, Mustafa Şahbazlar, Mehmet Türker, Oğuzcan Kınıkoğlu, Tahir Yerlikaya, Gülhan Dinç, Ali Aytaç, Ziya Kalkan, Senar Ebinç, İlkay Gültürk, Merve Keskinkılıç, Zehra Sucuoğlu İşleyen, Dilek Çağlayan, Alper Türkel, Teoman Şakalar, Serhat Sekmek, Nilgün Yıldırım, Sinem Koçak, Kerem Okutur, Ahmet Özveren, Bengü Dursun, Sait Kitaplı, Orhan Önder Eren, İsmail Beypınar, İlhan Hacıbekiroğlu, Devrim Çabuk, Elanur Karaman, Ömer Acar, Semra Paydaş, Melek Karakurt Eryılmaz, Bilgin Demir, Zeynep Oruç, Mesut Yılmaz, Fatih Selçuk Biricik, Derya Kıvrak Salim, Özgür Tanrıverdi, Mutlu Doğan
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The studies evaluating the impact of Her2 levels in neoadjuvant setting have conflicting data. The aim of the study was to evaluate the prognostic impact of Her2 status in early triple negative breast cancer(TNBC). In the study TNBC patients
Externí odkaz:
https://doaj.org/article/ce3cface4e834236bebf941d34a5f4df
Autor:
Mustafa Korkmaz, Melek Karakurt Eryilmaz, Mustafa Karaağaç, Murat Araz, Özcan Çeneli, Mehmet Artaç
Publikováno v:
Anti-Cancer Drugs. 33:765-767
Ibrutinib is a Bruton tyrosine kinase inhibitor used in the treatment of chronic lymphocytic leukemia (CLL). Panitumumab, an mAb for epidermal growth factor receptor, is used in the treatment of metastatic colorectal cancer (CRC). We wanted to presen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1434ade2afa88c961154c74fe87a7b06
https://doi.org/10.1097/cad.0000000000001333
https://doi.org/10.1097/cad.0000000000001333
Autor:
Dilek Çağlayan, Melek Karakurt Eryilmaz, Mustafa Korkmaz, Mustafa Karaağaç, Engin Hendem, Mehmet Artaç
Publikováno v:
Anti-Cancer Drugs. 33:758-760
Pancreatic giant cell tumors (PGCTs), undifferentiated pancreatic carcinoma are rare tumors of the pancreas. PGCTs consist of osteoclastic, pleomorphic and mixed variants. PGCT is usually diagnosed at an advanced stage. PGCT has a worse prognosis tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f212036b894a59adec33196b7880df43
https://doi.org/10.1097/cad.0000000000001331
https://doi.org/10.1097/cad.0000000000001331
Autor:
Elvina Almuradova, Tugba Basoglu, Erdinc Nayir, Ertugrul Bayram, Semra Paydas, Ivo Gokmen, Serdar Karakaya, Berna Oksuzoglu, Dilek Erdem, Abdullah Sakin, Mustafa Atcı, Burcu Belen Gulbagcı, Ilhan Hacibekiroglu, Arif Hakan Onder, Serap Karaarslan, Melek Karakurt Eryilmaz, Mustafa Korkmaz, Ozan Yazıcı, Osman Sutcuoglu, Baran Akagunduz, Hacı Arak, Teoman Sakalar, Dincer Aydın, Yakup Iriagac, Ozkan Alan, Murat Midik, Denis Cetin, Asli Dilara Kip, Serdar Turhal, Turgut Kacan, Tolga Koseci
Publikováno v:
Neoplasma.
Sarcomatoid renal cell carcinoma (sRCC) is a rare variant of renal cell carcinoma (RCC) and is associated with a poor prognosis. We reviewed the outcomes of patients from oncology centers in Turkey. Our aim is to share our real-life experience and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba25b028364536e0d3a4f24a19d312b8
https://pubmed.ncbi.nlm.nih.gov/36620878
https://pubmed.ncbi.nlm.nih.gov/36620878
Autor:
Muzaffer Uğraklı, Muhammed Muhiddin Er, Melek Karakurt Eryilmaz, Mustafa Karaagac, Mehmet Artac, Meryem Karabacak, Murat Araz
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:2049-2052
Introduction Pazopanib is an agent that is being successfully used in soft tissue sarcomas. Some endocrine side effects may develop during pazopanib treatment. Here, we presented a case diagnosed with secondary adrenal insufficiency while being inves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7adbd25aa6bbc77b1afced471cd44af2
https://doi.org/10.1177/10781552211016081
https://doi.org/10.1177/10781552211016081